Glück Conviction Score™ ⓘ
EW
Edwards Lifesciences Corp
Effektiv: Neutral
Hoch
Bedeutung der Einstufung ⓘ
Insider
0,0
Keine Insider-Käufe
Institutionell
58,2
117 neu, 454 erhöht, -5754711K $ netto
Aktivist
33,4
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,69% (Stand: 31.05.2026)
Score-Verlauf (90 Tage)
Farbzonen = Stärkestufen (Sehr schwach … Sehr stark). Exit-Score unter der Schwelle = Timing-Ausstieg. Komponenten per Legende einblenden.
Kursverlauf (12 Monate)
Technische Indikatoren
Technical-Score basiert auf 12 Indikatoren (Trend, Momentum, Volatilität, Position) mit fixen Gewichten — wird aktuell nur informativ angezeigt und fließt nicht in den Glück Conviction Score ein. Integration nach Backtest-Kalibrierung (P5).
| Indikator | Signal | Gewicht | Wert | Detail | Beitrag |
|---|---|---|---|---|---|
| Kurs vs SMA50 | Bullisch | 10 % | 82.78 | +2.8 % vs SMA50 | |
| Kurs vs SMA200 | Bullisch | 15 % | 81.84 | +4.0 % vs SMA200 | |
| EMA20 vs EMA50 | Bullisch | 5 % | 85.34 | EMA50: 83.84 | |
| MACD-Histogramm | Bärisch | 10 % | -0.222 | Bearisch | |
| RSI(14) | Neutral | 10 % | 50.9 | Neutral (30–70) | |
| Stoch %K(14) | Neutral | 5 % | 30.7 | Neutral | |
| ADX(14)+DI | Neutral | 10 % | 17.8 | +DI: 16.3 / −DI: 19.7 | |
| Z-Score(60) | Neutral | 5 % | 0.92 | In Range | |
| 52W-Position | Bullisch | 5 % | 80.3 % | Hoch 88.16 / Tief 72.65 | |
| Bollinger(20,2σ) | Neutral | 5 % | 45.1 % | Upper 89.41 / Mid 85.49 / Lower 81.58 | |
| LinReg-Slope(60) | Bullisch | 10 % | +0.1102 | R²=0.47 / annualisiert +33.6 % |
Insider-Transaktionen (12 Monate) ⓘ
| Datum | Insider | Rolle | Typ | Stückzahl | Kurs | Wert (USD) | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | Dahl Andrew M. | Officer, SVP, Corporate Controller | Open Market Sale | -568 | 86,08 | -48.852,69 | -8,6% | |
| 2026-05-27 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -23.145 | 86,42 | -2.000.193,21 | -352,8% | |
| 2026-05-22 | Chopra Daveen | Officer, CVP, TMTT & Surgical | Open Market Sale | -1.500 | 84,60 | -126.905,25 | -22,4% | |
| 2026-05-18 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -620 | 81,14 | -50.306,80 | -8,9% | |
| 2026-05-15 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -9.968 | 82,07 | -818.105,66 | -144,3% | |
| 2026-05-15 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -8.000 | 81,82 | -654.572,80 | -115,5% | |
| 2026-05-12 | Zovighian Bernard J | Director, Officer, CEO | Open Market Sale | -35.506 | 77,92 | -2.766.762,44 | -488,0% | |
| 2026-05-12 | Zovighian Bernard J | Director, Officer, CEO | Open Market Sale | -845 | 78,40 | -66.250,28 | -11,7% | |
| 2026-05-11 | Markowitz Wayne | Officer, CVP, JAPAC | Open Market Sale | -593 | 79,73 | -47.279,89 | -8,3% | |
| 2026-05-04 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -1.019 | 83,98 | -85.575,62 | -15,1% | |
| 2026-05-01 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -1.000 | 82,99 | -82.988,90 | -14,6% | |
| 2026-05-01 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -19 | 83,99 | -1.595,77 | -0,3% | |
| 2026-04-09 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -4.676 | 80,50 | -376.400,70 | -66,4% | |
| 2026-04-09 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -8.324 | 79,79 | -664.143,66 | -117,1% | |
| 2026-04-06 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -1.019 | 80,98 | -82.522,70 | -14,6% | |
| 2026-04-02 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -18.004 | 80,05 | -1.441.209,40 | -254,2% | |
| 2026-04-02 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -4.676 | 80,59 | -376.845,85 | -66,5% | |
| 2026-03-11 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -5.099 | 84,46 | -430.668,17 | -76,0% | |
| 2026-03-11 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -1.019 | 85,38 | -87.004,46 | -15,3% | |
| 2026-03-11 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -7.901 | 85,21 | -673.227,62 | -118,7% | |
| 2026-03-02 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -11.340 | 85,93 | -974.430,32 | -171,9% | |
| 2026-02-25 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -24.000 | 83,84 | -2.012.076,00 | -354,9% | |
| 2026-02-12 | Zovighian Bernard J | Director, Officer, CEO | Open Market Sale | -19.898 | 76,61 | -1.524.451,44 | -268,9% | |
| 2026-02-12 | Zovighian Bernard J | Director, Officer, CEO | Open Market Sale | -2.532 | 77,13 | -195.289,87 | -34,4% | |
| 2026-01-09 | Lippis Daniel J. | Officer, CVP, TAVR | Open Market Sale | -1.019 | 85,70 | -87.332,07 | -15,4% | |
| 2026-01-06 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -2.632 | 84,62 | -222.721,42 | -39,3% | |
| 2026-01-06 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -8.708 | 85,98 | -748.707,74 | -132,1% | |
| 2025-12-12 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -5.486 | 83,79 | -459.681,79 | -81,1% | |
| 2025-12-12 | STONE HEISZ LESLIE | Director | Open Market Sale | -2.615 | 83,41 | -218.119,50 | -38,5% | |
| 2025-12-12 | Lippis Daniel J. | Officer, CVP, JAPAC | Open Market Sale | -1.019 | 84,03 | -85.625,25 | -15,1% | |
| 2025-12-12 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -5.900 | 83,74 | -494.066,00 | -87,1% | |
| 2025-12-11 | Chopra Daveen | Officer, CVP, TMTT & Surgical | Open Market Sale | -2.000 | 84,38 | -168.750,20 | -29,8% | |
| 2025-12-10 | Zovighian Bernard J | Director, Officer, CEO | Open Market Sale | -3.863 | 83,45 | -322.367,35 | -56,9% | |
| 2025-12-10 | BOBO DONALD E JR | Officer, CVP,Strategy/Corp Development | Open Market Sale | -11.340 | 83,83 | -950.581,17 | -167,7% | |
| 2025-12-09 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -7.700 | 84,47 | -650.412,07 | -114,7% | |
| 2025-12-08 | Zovighian Bernard J | Director, Officer, CEO | Open Market Sale | -21.487 | 85,21 | -1.831.006,11 | -323,0% | |
| 2025-12-08 | Markowitz Wayne | Officer, CVP, JAPAC | Open Market Sale | -583 | 86,01 | -50.143,83 | -8,8% | |
| 2025-11-10 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -10.026 | 83,02 | -832.359,52 | -146,8% | |
| 2025-11-10 | Lippis Daniel J. | Officer, CVP, JAPAC | Open Market Sale | -1.020 | 82,55 | -84.196,00 | -14,9% | |
| 2025-11-10 | Ullem Scott B. | Officer, CVP, Chief Financial Officer | Open Market Sale | -2.974 | 83,30 | -247.733,90 | -43,7% | |
| 2025-08-25 | Chopra Daveen | Officer, CVP, TMTT | Open Market Sale | -2.500 | 81,95 | -204.865,00 | -36,1% | |
| 2025-08-18 | Wood Larry L | Officer, Global President TAVR & Surg | Open Market Sale | -8.950 | 78,06 | -698.679,07 | -123,2% | |
| 2025-07-28 | Lippis Daniel J. | Officer, CVP, JAPAC | Open Market Sale | -4.114 | 79,46 | -326.900,50 | -57,7% | |
| 2025-06-16 | Wood Larry L | Officer, Global President TAVR & Surg | Open Market Sale | -8.950 | 75,23 | -673.268,23 | -118,8% |
Fondsaktivität (Vorquartalsvergleich) ⓘ
| Fonds | Aktuell (Stk) | Vorquartal (Stk) | Veränderung (Stk) | Wert (USD) | Status | Δ | Trend |
|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC | 70.079.435 | 0 | 70.079.435 | 5.974.271.834 | Neu | +100,0% | |
| BlackRock, Inc. | 52.728.933 | 52.461.915 | 267.018 | 4.222.532.929 | Aufgestockt | +0,5% | |
| JPMORGAN CHASE & CO | 26.349.452 | 0 | 26.349.452 | 2.246.290.811 | Neu | +100,0% | |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26.407.018 | 0 | 26.407.018 | 2.114.674.001 | Neu | +100,0% | |
| STATE STREET CORP | 26.296.399 | 25.991.524 | 304.875 | 2.105.815.632 | Aufgestockt | +1,2% | |
| WELLINGTON MANAGEMENT GROUP LLP | 22.011.101 | 21.793.949 | 217.152 | 1.762.648.967 | Aufgestockt | +1,0% | |
| FMR LLC | 14.503.770 | 16.582.547 | -2.078.777 | 1.161.461.852 | Reduziert | -12,5% | |
| GEODE CAPITAL MANAGEMENT, LLC | 13.133.777 | 12.784.902 | 348.875 | 1.047.048.684 | Aufgestockt | +2,7% | |
| JENNISON ASSOCIATES LLC | 13.066.274 | 13.780.515 | -714.241 | 1.046.347.238 | Reduziert | -5,2% | |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 12.811.902 | 7.732.010 | 5.079.892 | 1.025.974.197 | Aufgestockt | +65,7% | |
| Ninety One UK Ltd | 12.396.143 | 7.734.946 | 4.661.197 | 992.683.018 | Aufgestockt | +60,3% | |
| NORGES BANK | 9.427.396 | 0 | 9.427.396 | 803.685.509 | Neu | +100,0% | |
| MORGAN STANLEY | 7.060.876 | 7.314.292 | -253.416 | 565.435.098 | Reduziert | -3,5% | |
| BROWN ADVISORY INC | 7.029.512 | 7.332.126 | -302.614 | 562.923.315 | Reduziert | -4,1% | |
| DEUTSCHE BANK AG\ | 6.186.423 | 5.578.796 | 607.627 | 495.408.755 | Aufgestockt | +10,9% | |
| NORTHERN TRUST CORP | 5.824.369 | 5.880.488 | -56.119 | 466.415.469 | Reduziert | -1,0% | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.458.148 | 5.383.637 | 74.511 | 437.088.491 | Aufgestockt | +1,4% | |
| Artisan Partners Limited Partnership | 5.201.144 | 1.166.715 | 4.034.429 | 416.507.641 | Aufgestockt | +345,8% | |
| GOLDMAN SACHS GROUP INC | 5.142.050 | 3.498.712 | 1.643.338 | 411.775.393 | Aufgestockt | +47,0% | |
| Invesco Ltd. | 4.815.350 | 3.461.198 | 1.354.152 | 385.613.190 | Aufgestockt | +39,1% | |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 4.800.000 | 4.800.000 | 0 | 384.384.000 | Unverändert | 0,0% | |
| Legal & General Group Plc | 4.449.554 | 4.415.969 | 33.585 | 356.320.278 | Aufgestockt | +0,8% | |
| BANK OF AMERICA CORP /DE/ | 3.883.419 | 1.671.211 | 2.212.208 | 310.984.191 | Aufgestockt | +132,4% | |
| ALLIANCEBERNSTEIN L.P. | 3.467.355 | 2.512.284 | 955.071 | 295.592.014 | Aufgestockt | +38,0% | |
| DIMENSIONAL FUND ADVISORS LP | 3.636.881 | 3.600.884 | 35.997 | 291.233.611 | Aufgestockt | +1,0% | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 3.557.088 | 3.448.040 | 109.048 | 284.851.607 | Aufgestockt | +3,2% | |
| PRIMECAP MANAGEMENT CO/CA/ | 3.422.791 | 3.418.791 | 4.000 | 274.097.103 | Aufgestockt | +0,1% | |
| VANGUARD FIDUCIARY TRUST CO | 3.265.355 | 0 | 3.265.355 | 261.489.628 | Neu | +100,0% | |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2.932.796 | 3.114.850 | -182.054 | 234.858.304 | Reduziert | -5,8% | |
| Nuveen, LLC | 2.893.244 | 3.374.231 | -480.987 | 231.690.980 | Reduziert | -14,3% | |
| UBS Group AG | 2.862.176 | 1.966.560 | 895.616 | 229.203.054 | Aufgestockt | +45,5% | |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 2.768.995 | 1.109.207 | 1.659.788 | 221.741.000 | Aufgestockt | +149,6% | |
| Amundi | 2.670.209 | 2.658.038 | 12.171 | 213.830.337 | Aufgestockt | +0,5% | |
| Mirova US LLC | 2.627.315 | 2.739.071 | -111.756 | 210.395.385 | Reduziert | -4,1% | |
| ROYAL BANK OF CANADA | 2.446.999 | 2.071.198 | 375.801 | 195.956.000 | Aufgestockt | +18,1% | |
| Neuberger Berman Group LLC | 2.350.179 | 328.766 | 2.021.413 | 188.176.825 | Aufgestockt | +614,8% | |
| RAYMOND JAMES FINANCIAL INC | 2.224.213 | 2.137.309 | 86.904 | 178.103.394 | Aufgestockt | +4,1% | |
| Russell Investments Group, Ltd. | 2.155.798 | 1.822.386 | 333.412 | 172.539.071 | Aufgestockt | +18,3% | |
| BNP Paribas Asset Management Holding S.A. | 2.104.677 | 2.185.653 | -80.976 | 168.542.535 | Reduziert | -3,7% | |
| Allspring Global Investments Holdings, LLC | 2.060.891 | 641.869 | 1.419.022 | 167.468.003 | Aufgestockt | +221,1% | |
| Allianz Asset Management GmbH | 2.010.211 | 2.238.070 | -227.859 | 160.977.697 | Reduziert | -10,2% | |
| MARSHALL WACE, LLP | 1.996.377 | 5.925.627 | -3.929.250 | 159.869.871 | Reduziert | -66,3% | |
| MILLENNIUM MANAGEMENT LLC | 1.985.221 | 6.502.638 | -4.517.417 | 158.976.498 | Reduziert | -69,5% | |
| NORDEA INVESTMENT MANAGEMENT AB | 2.024.887 | 3.642.618 | -1.617.731 | 157.536.208 | Reduziert | -44,4% | |
| AQR CAPITAL MANAGEMENT LLC | 1.968.753 | 2.241.751 | -272.998 | 157.096.585 | Reduziert | -12,2% | |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.890.859 | 428.621 | 1.462.238 | 151.419.989 | Aufgestockt | +341,1% | |
| Point72 Asset Management, L.P. | 1.831.237 | 478.767 | 1.352.470 | 146.645.459 | Aufgestockt | +282,5% | |
| HSBC HOLDINGS PLC | 1.828.162 | 2.206.174 | -378.012 | 146.267.090 | Reduziert | -17,1% | |
| Woodline Partners LP | 1.768.176 | 1.070.634 | 697.542 | 141.595.534 | Aufgestockt | +65,2% | |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.714.280 | 1.455.842 | 258.438 | 137.279.542 | Aufgestockt | +17,8% |
Top-Fondshalter (Stand: 31.03.2026) ⓘ
| Fonds | Anteile | Vorquartal (Stk) | Δ | Wert (USD) | Anteil (%) |
|---|---|---|---|---|---|
| BlackRock, Inc. | 52.728.933 | 52.461.915 | +0,5% | 4.222.532.929 | 11,98 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 26.407.018 | 0 | +100,0% | 2.114.674.001 | 6,00 |
| STATE STREET CORP | 26.296.399 | 25.991.524 | +1,2% | 2.105.815.632 | 5,98 |
| WELLINGTON MANAGEMENT GROUP LLP | 22.011.101 | 21.793.949 | +1,0% | 1.762.648.967 | 5,00 |
| JPMORGAN CHASE & CO | 21.889.712 | 26.349.452 | -16,9% | 1.740.232.166 | 4,94 |
| FMR LLC | 14.503.770 | 16.582.547 | -12,5% | 1.161.461.852 | 3,30 |
| GEODE CAPITAL MANAGEMENT, LLC | 13.133.777 | 12.784.902 | +2,7% | 1.047.048.684 | 2,97 |
| JENNISON ASSOCIATES LLC | 13.066.274 | 13.780.515 | -5,2% | 1.046.347.238 | 2,97 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 12.811.902 | 7.732.010 | +65,7% | 1.025.974.197 | 2,91 |
| Ninety One UK Ltd | 12.396.143 | 7.734.946 | +60,3% | 992.683.018 | 2,82 |
| MORGAN STANLEY | 7.060.876 | 7.314.292 | -3,5% | 565.435.098 | 1,60 |
| BROWN ADVISORY INC | 7.029.512 | 7.332.126 | -4,1% | 562.923.315 | 1,60 |
| DEUTSCHE BANK AG\ | 6.186.423 | 5.578.796 | +10,9% | 495.408.755 | 1,41 |
| NORTHERN TRUST CORP | 5.824.369 | 5.880.488 | -1,0% | 466.415.469 | 1,32 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 5.458.148 | 5.383.637 | +1,4% | 437.088.491 | 1,24 |
| Artisan Partners Limited Partnership | 5.201.144 | 1.166.715 | +345,8% | 416.507.641 | 1,18 |
| GOLDMAN SACHS GROUP INC | 5.142.050 | 3.498.712 | +47,0% | 411.775.393 | 1,17 |
| Invesco Ltd. | 4.815.350 | 3.461.198 | +39,1% | 385.613.190 | 1,09 |
| WELLCOME TRUST LTD (THE) as trustee of the WELLCOME TRUST | 4.800.000 | 4.800.000 | 0,0% | 384.384.000 | 1,09 |
| Legal & General Group Plc | 4.449.554 | 4.415.969 | +0,8% | 356.320.278 | 1,01 |
Halter-Trend (6 Quartale)
| Periode | Status | Halter | Anteile (Mio) | Wert (Mio $) |
|---|---|---|---|---|
| 31.03.2026 | ✓ | 1.276 | 496,8 | 38.633 |
| 31.12.2025 | ✓ | 1.299 | 511,0 | 42.261 |
| 30.09.2025 | ✓ | 1.258 | 530,4 | 40.274 |
| 30.06.2025 | ✓ | 1.253 | 499,2 | 37.860 |
| 31.03.2025 | ✓ | 1.194 | 513,0 | 36.165 |
| 31.12.2024 | ✓ | 1.205 | 523,5 | 37.432 |
Top 10 Neueinsteiger
| Fonds | Anteile | Wert (USD) ⓘ |
|---|---|---|
| NORGES BANK | 9.427.396 | 803.685.509 |
| Artisan Partners Limited Partnership | 1.166.715 | 99.462.474 |
| NOMURA ASSET MANAGEMENT INTERNATIONAL INC. | 1.109.207 | 94.560.000 |
| PFA Pension, Forsikringsaktieselskab | 543.261 | 46.829.110 |
| WORLDQUANT MILLENNIUM ADVISORS LLC | 452.566 | 38.581.252 |
| Catalio Capital Management, LP | 187.048 | 15.945.842 |
| GLENMEDE TRUST CO NA | 174.406 | 14.868.110 |
| BLI - Banque de Luxembourg Investments | 169.530 | 14.614.955 |
| Eurizon Capital SGR S.p.A. | 160.278 | 13.694.249 |
| ONTARIO TEACHERS PENSION PLAN BOARD | 134.451 | 11.461.948 |
Top 10 Aufstocker
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| MILLENNIUM MANAGEMENT LLC | 6.502.638 | 3.994.941 | +159.3 % | 554.349.889 |
| MARSHALL WACE, LLP | 5.925.627 | 2.359.128 | +66.1 % | 505.159.711 |
| FMR LLC | 16.582.547 | 2.003.735 | +13.7 % | 1.413.662.134 |
| ALLIANCEBERNSTEIN L.P. | 2.512.284 | 1.480.055 | +143.4 % | 214.172.211 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 2.126.755 | 1.267.918 | +147.6 % | 181.307 |
| JPMORGAN CHASE & CO | 26.349.452 | 1.170.026 | +4.6 % | 2.246.290.811 |
| WELLINGTON MANAGEMENT GROUP LLP | 21.793.949 | 989.533 | +4.8 % | 1.857.934.152 |
| CAISSE DE DEPOT ET PLACEMENT DU QUEBEC | 1.455.842 | 887.600 | +156.2 % | 124.110.531 |
| Handelsbanken Fonder AB | 1.203.504 | 840.513 | +231.6 % | 102.599 |
| MORGAN STANLEY | 7.314.292 | 804.942 | +12.4 % | 623.543.624 |
Top 10 Verkäufer
| Fonds | Anteile | Δ Anteile ⓘ | Δ % ⓘ | Wert (USD) ⓘ |
|---|---|---|---|---|
| Holocene Advisors, LP | 2.251.043 | -2.495.651 | -52.6 % | 191.901.416 |
| CITADEL ADVISORS LLC | 2.550.027 | -2.132.043 | -45.5 % | 217.389.802 |
| BlackRock, Inc. | 52.461.915 | -1.832.258 | -3.4 % | 4.472.378.277 |
| DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt am Main | 7.732.010 | -1.508.187 | -16.3 % | 659.153.842 |
| Nuveen, LLC | 3.374.231 | -1.167.195 | -25.7 % | 287.653.194 |
| MACQUARIE GROUP LTD | 111.268 | -1.116.898 | -90.9 % | 9.485.597 |
| JANE STREET GROUP, LLC | 874.500 | -999.648 | -53.3 % | 74.551.125 |
| NORDEA INVESTMENT MANAGEMENT AB | 3.642.618 | -604.346 | -14.2 % | 312.645.903 |
| DEUTSCHE BANK AG\ | 5.578.796 | -584.849 | -9.5 % | 475.592.359 |
| UBS Group AG | 1.966.560 | -486.975 | -19.8 % | 167.649.241 |
Aktivisten & Großaktionäre (13D/13G) ⓘ
| Datum | Investor | Typ | Anteil | Aktien | Δ | Zweck |
|---|---|---|---|---|---|---|
| 30.04.2026 | Vanguard Capital Management | Passiv (13G) | 7,54 % | 43.477.533 | Neu | |
| 26.03.2026 | The Vanguard Group | Passiv (13G/A) | Ausstieg | 0 | -11,72 pp | |
| 17.10.2025 | BlackRock, Inc. | Passiv (13G/A) | 7,50 % | 44.267.376 | Neu | |
| 12.08.2025 | Wellington Management Group LLP | Passiv (13G/A) | 3,40 % | 19.826.483 | -1,83 pp | |
| 12.08.2025 | Wellington Investment Advisors Holdings LLP | Passiv (13G/A) | 3,40 % | 19.826.483 | -1,83 pp | |
| 12.08.2025 | Wellington Group Holdings LLP | Passiv (13G/A) | 3,40 % | 19.826.483 | -1,83 pp | |
| 30.01.2025 | The Vanguard Group | Passiv (13G/A) | 11,72 % | 69.131.602 | +1,33 pp | |
| 08.11.2024 | Wellington Group Holdings LLP | Passiv (13G) | 5,23 % | 31.532.725 | Neu | |
| 08.11.2024 | Wellington Management Group LLP | Passiv (13G) | 5,23 % | 31.532.725 | Neu | |
| 08.11.2024 | Wellington Investment Advisors Holdings LLP | Passiv (13G) | 5,23 % | 31.532.725 | Neu | |
| 04.10.2024 | The Vanguard Group | Passiv (13G/A) | 10,39 % | 62.594.108 | +1,76 pp | |
| 09.08.2024 | Morgan Stanley | Passiv (13G/A) | Ausstieg | 0 | -4,50 pp | |
| 09.08.2024 | Morgan Stanley Smith Barney LLC | Passiv (13G/A) | Ausstieg | 0 | -13,00 pp | |
| 13.02.2024 | The Vanguard Group | Passiv (13G/A) | 8,63 % | 52.362.913 | +0,29 pp | |
| 09.02.2024 | Parametric Portfolio Associates LLC | Passiv (13G/A) | 4,50 % | 1.497.036 | -0,90 pp | |
| 09.02.2024 | Morgan Stanley | Passiv (13G/A) | 4,50 % | 1.497.036 | -8,50 pp | |
| 09.02.2024 | Morgan Stanley | Passiv (13G/A) | 13,00 % | 4.325.771 | +7,60 pp | |
| 09.02.2024 | Morgan Stanley Smith Barney LLC | Passiv (13G/A) | 13,00 % | 4.325.771 | -0,60 pp | |
| 25.01.2024 | . BlackRock, Inc. | Passiv (13G/A) | 8,60 % | 52.171.889 | 0,00 pp | |
| 09.02.2023 | The Vanguard Group | Passiv (13G/A) | 8,34 % | 51.559.391 | +0,48 pp | |
| 09.02.2023 | Parametric Portfolio Associates LLC | Passiv (13G) | 5,40 % | 1.819.359 | Neu | |
| 09.02.2023 | Morgan Stanley | Passiv (13G) | 5,40 % | 1.819.359 | -8,20 pp | |
| 09.02.2023 | Morgan Stanley | Passiv (13G/A) | 13,60 % | 4.558.111 | +0,20 pp | |
| 09.02.2023 | Morgan Stanley Smith Barney LLC | Passiv (13G/A) | 13,60 % | 4.558.111 | +0,20 pp | |
| 07.02.2023 | . BlackRock, Inc. | Passiv (13G/A) | 8,60 % | 53.060.508 | -0,50 pp | |
| 14.02.2022 | Saba Capital Management GP, LLC | Passiv (13G/A) | Ausstieg | 0 | -5,00 pp | |
| 14.02.2022 | Saba Capital Management, L.P. | Passiv (13G/A) | Ausstieg | 0 | -5,00 pp | |
| 14.02.2022 | Boaz R. Weinstein | Passiv (13G/A) | Ausstieg | 0 | -5,00 pp | |
| 09.02.2022 | The Vanguard Group | Passiv (13G/A) | 7,86 % | 49.076.649 | +0,10 pp | |
| 09.02.2022 | Morgan Stanley Smith Barney LLC | Passiv (13G/A) | 13,40 % | 4.498.083 | +3,40 pp | |
| 09.02.2022 | Morgan Stanley | Passiv (13G/A) | 13,40 % | 4.498.083 | +3,40 pp | |
| 03.02.2022 | . BlackRock, Inc. | Passiv (13G/A) | 9,10 % | 57.040.983 | -0,30 pp |
US Congress Trades (STOCK Act)
| Datum | Mitglied | Partei | Kammer | Typ | Betrag-Bereich |
|---|---|---|---|---|---|
| 19.11.2025 | Josh Gottheimer | – | House | Verkauf | $1,001 – $15,000 |
| 12.05.2025 | Jefferson Shreve | – | House | Verkauf | $50,001 – $100,000 |
| 21.04.2025 | Bruce Westerman | – | House | Verkauf | $1,001 – $15,000 |
| 08.04.2025 | Rob Bresnahan | – | House | Kauf | $1,001 – $15,000 |
| 07.04.2025 | Jefferson Shreve | – | House | Kauf | $15,001 – $50,000 |
| 03.03.2025 | Bruce Westerman | – | House | Kauf | $1,001 – $15,000 |
| 20.08.2024 | Markwayne Mullin | – | Senate | Verkauf | $15,001 – $50,000 |
Quelle: House eFD & Senate eFD (STOCK Act PTR). Betragsangaben sind Bereichsangaben — keine Exaktwerte. Tiefenanalyse für diese Aktie → · Alle Kongress-Bestände →
Stammdaten
Edwards Lifesciences Corporation bietet Produkte und Technologien für strukturelle Herzerkrankungen sowie kritische Versorgung und chirurgische Überwachung in den Vereinigten Staaten, Europa, Japan und international. Es bietet transkatheter Herzklappenersatzprodukte für den minimalinvasiven Ersatz von Herzklappen an; sowie transkatheter Herzklappenreparatur- und Ersatzprodukte zur Behandlung von Mitral- und Trikuspidalklappenerkrankungen. Das Unternehmen bietet auch die PASCAL- und Cardioband-transkatheter-Klappenreparatursysteme für minimalinvasive Therapie. Darüber hinaus bietet es chirurgische Lösungen für strukturelle Herzen, wie Aorten-Chirurgie-Ventil unter dem Namen INSPIRIS; KONECT RESILIA, ein vorgefertigtes Aorten-Gewebe-Ventil-Konduit für Patienten, die einen Ersatz des Ventils, der Wurzel und der aufsteigenden Aorta benötigen; und HARPOON Beating Heart Mitral Valve Repair System für Patienten mit degenerativer Mitralklappeninsuffizienz. Weiterhin bietet das Unternehmen kritische Versorgungslösungen an, einschließlich fortgeschrittener Hämodynamik-Überwachungssysteme zur Messung der Herzfunktion und des Flüssigkeitsstatus eines Patienten in chirurgischen und Intensivpflegeumgebungen; sowie Acumen Hypotension Prediction Index-Software, die Kliniker vor einer gefährlich niedrigen Blutdruckentwicklung warnt. Das Unternehmen vertreibt seine Produkte über eine direkte Vertriebsorganisation und unabhängige Verteiler. Edwards Lifesciences Corporation wurde 1958 gegründet und hat seinen Sitz in Irvine, Kalifornien.
Unternehmen & Branche
| Name | Edwards Lifesciences Corp |
|---|---|
| Ticker | EW |
| CIK | 0001099800 |
| Boerse | NYSE |
| Sektor | Healthcare |
| Industrie | Medical - Devices |
| SIC | 3842 · Orthopedic, Prosthetic & Surgical Appliances & Supplies |
Wertpapier & Kennzahlen
| CUSIP | 28176E108 |
|---|---|
| ISIN | US28176E1082 |
| Typ | Common Stock |
| Marktkapitalisierung | 49,93 Mrd. USD |
| KGV (P/E) | 46,98 |
| Beta | 0,85 |
Bewertung
| KBV (P/B) | 4,83 vs. 13,85 (2021) ▼ |
|---|---|
| KUV (P/S) | 8,23 vs. 15,45 (2021) ▼ |
| EV/EBITDA | 33,6 vs. 44,2 (2021) ▼ |
| FCF-Rendite | 2,7 % vs. 1,7 % (2021) ▲ |
| Buyback-Rendite | 1,8 % vs. 0,6 % (2021) ▲ |
Qualität & Bilanz
| Bruttomarge | 78,0 % vs. 76,1 % (2021) ▲ |
|---|---|
| Operative Marge | 20,8 % vs. 32,3 % (2021) ▼ |
| Nettomarge | 17,7 % vs. 28,7 % (2021) ▼ |
| ROIC | 9,7 % vs. 23,0 % (2021) ▼ |
| Nettoverschuldung/EBITDA | -1,6 vs. -0,1 (2021) ▼ |
| Zinsdeckungsgrad | 62,0 vs. 91,9 (2021) ▼ |
Basis: SEC-XBRL-Jahresabschluss bis 31.12.2025, Multiples mit aktueller Marktkapitalisierung (trailing), Vergleich: GJ bis 2021. Kennzahlen erklärt →
Kennzahlen-Historie (5 Jahre) – Tabelle & Verlauf
| Kennzahl | 2021 | 2022 | 2023 | 2024 | 2025 | Verlauf |
|---|---|---|---|---|---|---|
| Bewertung | ||||||
| KBV (P/B) | 13,85 | 7,82 | 6,89 | 4,36 | 4,79 | |
| KUV (P/S) | 15,45 | 10,17 | 9,15 | 8,01 | 8,16 | |
| EV/EBITDA | 44,2 | 27,7 | 31,2 | 26,9 | 33,3 | |
| FCF-Rendite | 1,7 % | 2,1 % | 1,4 % | 0,7 % | 2,7 % | |
| Buyback-Rendite | 0,6 % | 3,8 % | 1,9 % | 2,7 % | 1,8 % | |
| Qualität & Bilanz | ||||||
| Bruttomarge | 76,1 % | 83,8 % | 80,5 % | 79,5 % | 78,0 % | |
| Operative Marge | 32,3 % | 33,6 % | 26,1 % | 25,3 % | 20,8 % | |
| Nettomarge | 28,7 % | 34,1 % | 28,0 % | 76,7 % | 17,7 % | |
| ROIC | 23,0 % | 23,4 % | 19,1 % | 39,0 % | 9,7 % | |
| Nettoverschuldung/EBITDA | -0,1 | 0,0 | -0,3 | -1,5 | -1,6 | |
| Zinsdeckungsgrad | 91,9 | 78,0 | 74,4 | 69,6 | 62,0 | |
Basis: SEC-XBRL-Jahresabschlüsse, Multiples je Geschäftsjahr mit Marktkapitalisierung zum Bilanzstichtag (point-in-time).
Externe Quelle:
SEC EDGAR »
Externe Links: Yahoo Finance » · OnVista »
Finanzkennzahlen (SEC XBRL) ⓘ
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2026-03-31 | 10-Q | 1.648.600.000 | 380.700.000 | 0,66 | 13.321.200.000 | 10.327.500.000 |
| 2025-12-31 | 10-K | 6.067.600.000 | 1.073.500.000 | 1,83 | 13.697.200.000 | 10.337.600.000 |
| 2025-09-30 | 10-Q | 1.553.100.000 | 291.100.000 | 0,50 | 13.272.200.000 | 10.205.000.000 |
| 2025-06-30 | 10-Q | 1.532.200.000 | 333.200.000 | 0,56 | 13.488.700.000 | 10.545.300.000 |
| 2025-03-31 | 10-Q | 1.412.700.000 | 358.000.000 | 0,61 | 13.022.300.000 | 10.128.700.000 |
| 2024-12-31 | 10-K | 5.439.500.000 | 4.174.600.000 | 6,97 | 13.055.300.000 | 9.998.400.000 |
| 2024-09-30 | 10-Q | 1.354.400.000 | 3.070.800.000 | 5,13 | 12.971.200.000 | 9.545.600.000 |
| 2024-06-30 | 10-Q | 1.385.900.000 | 366.300.000 | 0,61 | 10.099.300.000 | 7.437.400.000 |
| 2024-03-31 | 10-Q | 1.598.200.000 | 351.900.000 | 0,58 | 9.736.300.000 | 7.117.900.000 |
| 2023-12-31 | 10-K | 5.010.000.000 | 1.402.400.000 | 2,30 | 9.363.200.000 | 6.650.000.000 |
| 2023-09-30 | 10-Q | 1.243.400.000 | 384.900.000 | 0,63 | 9.370.800.000 | 6.657.500.000 |
| 2023-06-30 | 10-Q | 1.295.500.000 | 307.100.000 | 0,50 | 9.004.000.000 | 6.375.700.000 |
| 2023-03-31 | 10-Q | 1.459.600.000 | 340.500.000 | 0,56 | 8.651.200.000 | 5.978.000.000 |
| 2022-12-31 | 10-K | 4.464.000.000 | 1.521.900.000 | 2,44 | 8.292.500.000 | 5.806.700.000 |
| 2022-09-30 | 10-Q | 1.319.000.000 | 343.500.000 | 0,55 | 8.638.200.000 | 6.217.800.000 |
| 2022-06-30 | 10-Q | 1.373.900.000 | 406.400.000 | 0,65 | 8.425.100.000 | 5.943.600.000 |
| 2022-03-31 | 10-Q | 1.341.200.000 | 0,59 | 8.419.900.000 | 5.844.900.000 | |
| 2021-12-31 | 10-K | 5.232.500.000 | 1.503.100.000 | 2,38 | 8.502.600.000 | 5.835.900.000 |
| 2021-09-30 | 10-Q | 1.310.200.000 | 0,54 | 8.160.300.000 | 5.541.300.000 | |
| 2021-06-30 | 10-Q | 1.376.000.000 | 0,78 | 7.662.100.000 | 5.133.300.000 |
Umsatz nach Segmenten & Regionen ⓘ
Geschäftssegmente
| Segment | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| Transcatheter Aortic Valve Replacement | 4,5 Mrd. | 4,1 Mrd. | 3,9 Mrd. | 3,5 Mrd. | 3,4 Mrd. | 74,0 % | +9,3% | |
| Surgical Heart Valve Therapy | 1,0 Mrd. | 981,3 Mio. | 932,6 Mio. | 829,7 Mio. | 889,1 Mio. | 17,0 % | +4,9% | |
| Transcatheter Mitral And Tricuspid Therapies | 550,6 Mio. | 352,1 Mio. | 197,6 Mio. | 116,1 Mio. | 86,0 Mio. | 9,1 % | +56,4% | |
| Critical Care | – | – | – | – | 834,9 Mio. | – | – |
Regionen
| Region | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | Anteil | Δ | Trend |
|---|---|---|---|---|---|---|---|---|
| US | 3,5 Mrd. | 3,1 Mrd. | 3,0 Mrd. | 2,5 Mrd. | 2,5 Mrd. | 58,4 % | +12,0% | |
| Europe | 1,3 Mrd. | 1,2 Mrd. | 1,2 Mrd. | 973,6 Mio. | 941,2 Mio. | 22,2 % | +13,6% | |
| Rest Of World | 709,2 Mio. | 601,4 Mio. | 550,2 Mio. | 435,8 Mio. | 429,4 Mio. | 11,8 % | +17,9% | |
| JP | 452,4 Mio. | 473,6 Mio. | 528,9 Mio. | 460,1 Mio. | 444,7 Mio. | 7,5 % | -4,5% |
Quartalsergebnisse (Earnings) ⓘ
| Quartal | Stichtag | Verkündet | Umsatz | EPS |
|---|---|---|---|---|
| Q1 2026 | 31.03.2026 | 06.05.2026 | 1,6 Mrd. USD | 0,66 |
| Q3 2025 | 30.09.2025 | 05.11.2025 | 1,6 Mrd. USD | 0,50 |
| Q2 2025 | 30.06.2025 | 06.08.2025 | 1,5 Mrd. USD | 0,56 |
| Q1 2025 | 31.03.2025 | 06.05.2026 | 1,4 Mrd. USD | 0,61 |
| Q3 2024 | 30.09.2024 | 05.11.2025 | 1,4 Mrd. USD | 5,13 |
| Q2 2024 | 30.06.2024 | 06.08.2025 | 1,4 Mrd. USD | 0,61 |
| Q1 2024 | 31.03.2024 | 06.05.2025 | 1,3 Mrd. USD | 0,58 |
| Q3 2023 | 30.09.2023 | 06.11.2024 | 1,2 Mrd. USD | 0,63 |
| Q2 2023 | 30.06.2023 | 31.07.2024 | 1,3 Mrd. USD | 0,50 |
Einreichungs-Historie (10-K / 10-Q)
SEC-Einreichungs-Historie der Quartalsberichte (10-Q) und Jahresberichte
(10-K) der letzten sechs Jahre. Die Spalte „Verzögerung" zeigt die
Tage zwischen Berichtsstichtag und tatsächlicher Einreichung.
Suffix /A kennzeichnet nachträgliche Berichtigungen.
| Eingereicht | Form | Berichtsperiode | Verzögerung | |
|---|---|---|---|---|
| 06.05.2026 | 10-Q | 31.03.2026 | 36 Tage | SEC » |
| 25.02.2026 | 10-K | 31.12.2025 | 56 Tage | SEC » |
| 05.11.2025 | 10-Q | 30.09.2025 | 36 Tage | SEC » |
| 06.08.2025 | 10-Q | 30.06.2025 | 37 Tage | SEC » |
| 06.05.2025 | 10-Q | 31.03.2025 | 36 Tage | SEC » |
| 28.02.2025 | 10-K | 31.12.2024 | 59 Tage | SEC » |
| 06.11.2024 | 10-Q | 30.09.2024 | 37 Tage | SEC » |
| 31.07.2024 | 10-Q | 30.06.2024 | 31 Tage | SEC » |
| 29.04.2024 | 10-Q | 31.03.2024 | 29 Tage | SEC » |
| 12.02.2024 | 10-K | 31.12.2023 | 43 Tage | SEC » |
| 27.10.2023 | 10-Q | 30.09.2023 | 27 Tage | SEC » |
| 28.07.2023 | 10-Q | 30.06.2023 | 28 Tage | SEC » |
| 28.04.2023 | 10-Q | 31.03.2023 | 28 Tage | SEC » |
| 13.02.2023 | 10-K | 31.12.2022 | 44 Tage | SEC » |
| 28.10.2022 | 10-Q | 30.09.2022 | 28 Tage | SEC » |
| 29.07.2022 | 10-Q | 30.06.2022 | 29 Tage | SEC » |
| 28.04.2022 | 10-Q | 31.03.2022 | 28 Tage | SEC » |
| 14.02.2022 | 10-K | 31.12.2021 | 45 Tage | SEC » |
| 29.10.2021 | 10-Q | 30.09.2021 | 29 Tage | SEC » |
| 30.07.2021 | 10-Q | 30.06.2021 | 30 Tage | SEC » |
| 28.04.2021 | 10-Q | 31.03.2021 | 28 Tage | SEC » |
| 12.02.2021 | 10-K | 31.12.2020 | 43 Tage | SEC » |
| 26.10.2020 | 10-Q | 30.09.2020 | 26 Tage | SEC » |
| 27.07.2020 | 10-Q | 30.06.2020 | 27 Tage | SEC » |
Kritische 8-K Meldungen ⓘ
WARNUNG: Kritische 8-K-Meldung(en)
HOCH Abgang Schlüsselpersonen (08.05.2026)
HOCH Abgang Schlüsselpersonen (08.05.2026)
| Datum | Meldung | Schwere | Filing | Auszug |
|---|---|---|---|---|
| 08.05.2026 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 08.05.2025 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02 Departure of Directors or Certain Officers; Election of Directors… |
| 10.07.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 17.06.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | o Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 26.03.2024 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Section 13(a) of the Exchange Act. ☐ Item 5.02. Departure of Directors or Certain Officers; Election of Directors… |
| 08.12.2022 | Item 5.02 — Abgang Schlüsselpersonen | HOCH | SEC | Item 5.02 of this Current Report on Form 8-K and certain other organizational changes. A copy of the press release is… |
Fail-to-Deliver (6 Monate) ⓘ
| Datum | FTD-Menge | Kurs | Wert (USD) |
|---|---|---|---|
| 2026-05-14 | 5.572 | 81,39 | 453.505 |
| 2026-05-13 | 23.698 | 79,73 | 1.889.442 |
| 2026-04-15 | 3 | 78,20 | 235 |
| 2026-04-14 | 75 | 78,12 | 5.859 |
| 2026-04-10 | 100 | 79,15 | 7.915 |
| 2026-04-06 | 89 | 81,05 | 7.213 |
| 2026-03-31 | 76 | 79,50 | 6.042 |
| 2026-03-25 | 58 | 81,69 | 4.738 |
| 2026-03-24 | 106 | 82,02 | 8.694 |
| 2026-03-23 | 20.012 | 82,50 | 1.650.990 |
| 2026-03-16 | 35 | 81,81 | 2.863 |
| 2026-03-05 | 87 | 85,22 | 7.414 |
| 2026-03-02 | 560 | 86,47 | 48.423 |
| 2026-02-26 | 10 | 83,40 | 834 |
| 2026-02-25 | 10 | 82,40 | 824 |
| 2026-02-19 | 16 | 78,98 | 1.264 |
| 2026-02-09 | 151 | 78,71 | 11.885 |
| 2026-02-04 | 1.713 | 82,10 | 140.637 |
| 2026-02-03 | 1.915 | 82,65 | 158.275 |
| 2026-01-29 | 50 | 81,86 | 4.093 |
| 2026-01-27 | 17.324 | 84,27 | 1.459.893 |
| 2026-01-20 | 501 | 84,35 | 42.259 |
| 2025-12-19 | 1 | 84,80 | 85 |
| 2025-12-17 | 77.398 | 85,32 | 6.603.597 |